Compile Data Set for Download or QSAR
Report error Found 28 Enz. Inhib. hit(s) with all data for entry = 11221
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501080(CHEMBL3819506 | US12286422, Example 10)
Affinity DataKi:  5.20E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM588210(US11542254, Example canosic acid | US12286422, Exa...)
Affinity DataKi:  5.30E+3nMMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM736147(4-(3-((S)-3-Ethyl-4-(4'-fluoro-6- (((S)-pyrrolidin...)
Affinity DataKi:  1.00E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM736151((S)-1-(3-Fluoro-5-(4-(4-(pyrrolidin- 3-yloxy)-3-(4...)
Affinity DataKi:  1.40E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501081(CHEMBL3819020 | US12286422, Example 12)
Affinity DataKi:  1.60E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM689285(S)-(4-(3-Fluoro-5-(piperazin-1-yl) benzoyl)piperaz...)
Affinity DataKi:  1.90E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501086(CHEMBL3818707 | US12286422, Example 8)
Affinity DataKi:  2.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM736149(4-(3-Fluoro-5-((5)-4-(4'-fluoro-6- (((S)-pyrrolidi...)
Affinity DataKi:  2.20E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501083(CHEMBL3819165 | US12286422, Example 19)
Affinity DataKi:  2.50E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501078(CHEMBL3818097 | US12286422, Example 7)
Affinity DataKi:  3.50E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501092(CHEMBL3819088 | US12286422, Example 11)
Affinity DataKi:  3.70E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM736150((S)-1-(3-(4-(3-Cyclohexyl-4- (pyrrolidin-3-yloxy)b...)
Affinity DataKi:  3.90E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501093(CHEMBL3818263 | US12286422, Example 15)
Affinity DataKi:  4.50E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM736148(4-(3-Fluoro-5-((5)-4-(4'-fluoro-6- (((S)-pyrrolidi...)
Affinity DataKi:  4.50E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501090(CHEMBL3819332 | US12286422, Example 6)
Affinity DataKi:  4.80E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501082(CHEMBL3818667 | US12286422, Example 16)
Affinity DataKi:  5.30E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501085(CHEMBL3818058 | US12286422, Example 21)
Affinity DataKi:  5.50E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501091(CHEMBL3819368 | US12286422, Example 9)
Affinity DataKi:  5.70E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501077(CHEMBL3818956 | US12286422, Example 5)
Affinity DataKi:  6.70E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501084(CHEMBL3818280 | US12286422, Example 20)
Affinity DataKi:  6.90E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501097(CHEMBL3818207 | US12286422, Example 14)
Affinity DataKi:  7.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501094(CHEMBL3817935 | US12286422, Example 18)
Affinity DataKi:  7.60E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501089(CHEMBL3818949 | US12286422, Example 3)
Affinity DataKi:  8.20E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM736146(4-(3-Fluoro-5-((S)-4-(4'-fluoro-6- (((S)-pyrrolidi...)
Affinity DataKi:  1.10E+5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501087(CHEMBL3818840 | US12286422, Example 1)
Affinity DataKi:  1.30E+5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501076(CHEMBL3819443 | US12286422, Example 13)
Affinity DataKi:  1.70E+5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501096(CHEMBL3818029 | US12286422, Example 17)
Affinity DataKi:  4.90E+5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
University of Utah

US Patent
LigandPNGBDBM50501095(CHEMBL3818748 | US12286422, Example 4)
Affinity DataKi: >5.00E+5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/2/2023
Entry Details
Go to US Patent